Zhao Yanan, Cao Shanshan,Li Hong.. Clinical serological parameters in patients with alcoholic cirrhosis with or without ascites[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 183-186.
[1] 历有名. 酒精性肝病的流行病学特点. 实用肝脏病杂志,2012,15(3):180-182.
[2] 邹正升,赵军,王晓霞,等. 住院的酒精性肝病患者临床疾病特点分析. 实用肝脏病杂志,2014,17(1):26-29.
[3] 陈万青,郑荣寿,张思维,等. 2012年中国恶性肿瘤发病和死亡分析. 中国肿瘤,2016,25(1):1-8.
[4] 李佳红,付娜,牛学敏,等. 537例原发性肝癌病因及临床特点分析. 实用肝脏病杂志,2015,7,18(4):399-402.
[5] 中华医学会肝病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊疗指南. 实用肝脏病杂志,2007,10(1):4-5.
[6] 朱冰,刘鸿凌,刘利敏,等. 4132例酒精性肝病的临床特征分析. 中华肝脏病杂志,2015,23(9):680-683.
[7] 郝书理,李保森,孙颖,等. 130例酒精性肝衰竭患者临床特点与预后分析. 实用肝脏病杂志,2014,17(2):136-140.
[8] 姜佳丽,展玉涛,李莉. 肝硬化门静脉血栓患者血浆D-二聚体水平及其临床意义. 实用肝脏病杂志,2012,15(1):26-28.
[9] Hideaki T,Ryuta S,Yoshihito Y,et al. Correlation between hepatic blood flow and liver function in alcoholic liver cirrhosis. World J Gastroenterol,2014,20(45):17065-17074.
[10] 邓志凤,赵椿. 肝硬化、肝癌患者血小板参数纤维蛋白原及凝血酶原时间改变的临床意义. 临床肝胆病杂志,2007,23(5):374-375.
[11] 田秋菊,贾继东. 肝硬化腹水及相关并发症治疗新进展. 实用肝脏病杂志,2015,18(1):1-3.
[12] 陈丽. 人血白蛋白在肝硬化腹水患者中的系统评价. 湖南:湖南师范大学,2014:212.
[13] 全国酒精性肝病调查协作组. 全国酒精性肝病的多中心调查分析.中华消化杂志,2007,27(4):231-234.
[14] Clghlan A. Tumours thrive on an alcoholic diet. New Sci,2004,184(2478):14-16.
[15] Gianni T,Silvia L. Alcohol and hepatocellular carcinoma:A review and a point of view. World J Gastroenterol,2014,20(43):15943-15954.
[16] Thapi DR,Huasong T,Xun M,et al. Expression of the carboxy-terminal portion of MUC16/CA125 induces transformation and tumor invasion. PLoS One,2015,10(5):e0126633.
[17] 阮林松,许成新,陈世勇,等. 肝硬化患者血清及腹腔积液CA19-9、CA125检测的意义. 放射免疫学杂志,2011,24(1):107-108.
[18] Li Y,Li DJ,Chen J,et al. Application of joint detection of AFP,CA19-9,CA125 and CEA in identification and diagnosis of cholangiocarcinoma. Asian Pac J Cancer Prev,2015,16(8):3451-3455.
[19] 董欣敏,张剑,金雨. 原发性肝癌患者CEA、AFP、CA19-9和铁蛋白检测的意义. 实用肝脏病杂志,2014,17(3):295-296.
[20] Ripoll C,Keitel F,Hollenbach M,et al. Serum ferritin in patients with cirrhosis is associated with markers of liver insufficiency and circulatory dysfunction,but not of portal hypertension. J Clin Gastroenterol,2015,49(9):784-789.
[21] Facciorusso A,Del Prete V,Antonino M,et al. Serum ferritin as a new prognostic factor in hepatocellular carcinoma patients treated with radiofrequency ablation. J Gastroenterol Hepatol,2014,29(11):1905-1910.